MS Brain Health February 2016 Newsletter

Dear supporters

Welcome to the February 2016 edition of the Multiple Sclerosis Brain Health initiative newsletter.

Part of our current focus is to communicate the importance of brain health to MS specialist healthcare professionals across the globe. We will be presenting the findings of the report Brain health: time matters in multiple sclerosis at major congresses in North America (American Academy of Neurology) and the Middle East (MENACTRIMS; Middle East North Africa Committee for Research and Treatment in Multiple Sclerosis), and we have submitted abstracts to several other prominent meetings.

Our new series of short articles will help you to stay up to date with the latest MS research. Click on the links to read them on our website, and please consider sharing them more widely using the buttons at the bottom of each page.

Our other resources can help you to spread awareness of why brain health is important in MS. Here are three ways that you can assist in making a difference.

  1. Share articles from the MS Brain Health website. You might like to start with our 200-word summary, Why time matters in multiple sclerosis.
  2. Mention the report to relevant groups and individuals. We have received endorsements from 22 organizations on six continents. If you are involved with a professional or advocacy organization that has not yet endorsed Brain health: time matters in multiple sclerosis, please bring it to their attention and let us know how we can help.
  3. Tell us about your ideas. Since we launched the MS Brain Health initiative, a number of people have been in touch to suggest how they could become involved in their own countries. If you have ideas about this, we would love to hear from you!

Thank you for being part of the vision to create a better future for people with MS and their families.


Gavin Giovannoni, MD

Professor of Neurology and Chair of the MS Brain Health Steering Committee

On behalf of the MS Brain Health Steering Committee: Gavin Giovannoni, Peer Baneke, Helmut Butzkueven, Giancarlo Comi, Kathleen Costello, Jeremy Hobart, Gisela Kobelt and Christoph Thalheim


Preparation and publication of this newsletter was funded by a grant from AbbVie and by an educational grant from Novartis, both of whom had no influence on the content.


Related content